LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.105G>T
PTEN
· NP_000305.3:p.(Met35Ile)
· NM_000314.8
GRCh37: chr10:89653807 G>T
·
GRCh38: chr10:87894050 G>T
Gene:
PTEN
Transcript:
NM_000314.8
Final call
VUS
PM1 moderate
PM2 supporting
PP3 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Met35Ile)
gnomAD AF
0.0 (v4.1)
ClinVar
Likely pathogenic
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM1 moderate: p.Met35Ile lies in a reported statistically significant PTEN mutational hotspot.
2
PM2 supporting: the variant is absent from gnomAD v2.1 and has allele frequency 0.0 in gnomAD v4.1.
3
PP3 supporting: the REVEL score is 0.947, exceeding the PTEN VCEP threshold of 0.7.
Final determination:
Under the PTEN Expert Panel Version 3.2 framework, PM1 moderate plus PM2 and PP3 supporting does not meet any pathogenic or benign rule, so the result is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.105G>T produces missense p.Met35Ile, whereas the PTEN PVS1 decision tree covers null, splice-site, copy-number, and initiation-codon variants. |
cspec
vcep_pvs1_decisiontree_pten
|
| PS1 | Not assessed | Not assessed: Met35Arg and Met35Thr are alternate changes at residue 35, but neither is the identical pathogenic Met35Ile change required by PS1. |
cspec
vcep_mmc2
clinvar
|
| PS2 | Not assessed | Not assessed: no proband-level de novo finding, confirmed maternity and paternity, disease status, or family-history data are available. |
cspec
|
| PS3 | Not met | Not met: Table S2 reports high-confidence Cum_score -0.876619465 for M35I, above the PTEN PS3_Moderate threshold of ≤ -1.11. |
vcep_mmc2
PMID:29706350
|
| PS4 | Not assessed | Not assessed: no variant-specific case-control counts, odds ratio, confidence interval, or PTEN phenotype-specificity score is available for c.105G>T. |
cspec
|
| PM1 | Met | Met: PTEN M35 is reported in a statistically significant hotspot, satisfying the VCEP PM1 hotspot path despite lying outside listed catalytic motifs. |
cspec
|
| PM2 | Met | Met at supporting strength: gnomAD v4.1 AF is 0.0 (0/1,612,312 alleles), below the <0.00001 PM2 threshold, and the variant is absent from gnomAD v2.1. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the PTEN VCEP explicitly designates PM3 as not applicable to PTEN. |
cspec
|
| PM4 | N/A | Not applicable: p.Met35Ile is a missense substitution with no protein-length change, while PTEN PM4 is limited to in-frame indels and stop-loss variants. |
cspec
|
| PM5 | Not assessed | Not assessed: Met35Arg is pathogenic at the same residue, but the required BLOSUM62 comparison for Met35Ile is unavailable. |
cspec
vcep_mmc2
PMID:21828076
PMID:25875300
|
| PM6 | Not assessed | Not assessed: no presumed de novo observations, proband disease status, or family-history information are available for the PM6 requirements. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, co-segregation observations, or meioses are documented against the PTEN VCEP thresholds of 3, 5, or 7. |
cspec
|
| PP2 | Not assessed | Not assessed: the evidence does not establish both VCEP PP2 requirements—low benign missense variation and a common missense disease mechanism. |
cspec
|
| PP3 | Met | Met: REVEL score 0.947 exceeds the PTEN VCEP missense PP3 threshold of >0.7. |
cspec
revel
|
| PP4 | N/A | Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 Use 2 instead of applying PP4. |
cspec
|
| PP5 | N/A | Not applicable: the PTEN VCEP states that PP5 is not for use under the VCEP Review Committee recommendation. |
cspec
|
| BA1 | Not met | Not met: gnomAD v4.1 total allele frequency is 0.0 (0/1,612,312 alleles), below the >0.00056 BA1 threshold. |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: gnomAD v4.1 allele frequency is 0.0, below the PTEN VCEP BS1 supporting interval beginning at 0.0000043. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not met | Not met: gnomAD v4.1 reports 0 homozygotes, and no qualifying healthy or PHTS-unaffected homozygous observation is available. |
cspec
gnomad_v4
|
| BS3 | Not met | Not met: Table S2 reports high-confidence Cum_score -0.876619465 for M35I, below the PTEN BS3_Supporting requirement of phosphatase activity >0. |
vcep_mmc2
PMID:29706350
|
| BS4 | Not assessed | Not assessed: no affected family members with negative variant testing are documented in one family or across two families. |
cspec
|
| BP1 | N/A | Not applicable: the PTEN VCEP explicitly marks BP1 as Not Applicable. |
cspec
|
| BP2 | Not assessed | Not assessed: no documented trans observation or three qualifying cis/phase-unknown observations with different pathogenic PTEN variants are available. |
cspec
|
| BP3 | N/A | Not applicable: the PTEN VCEP specification explicitly marks BP3 as Not Applicable for this framework. |
cspec
|
| BP4 | Not met | Not met: REVEL score 0.947 is above, not below, the PTEN VCEP missense BP4 threshold of <0.5. |
cspec
revel
|
| BP5 | Not assessed | Not assessed: no two qualifying cases with a highly penetrant alternate diagnosis and non-overlapping PTEN history are documented for c.105G>T. |
cspec
|
| BP6 | N/A | Not applicable: the PTEN VCEP states that BP6 is not for use under the VCEP Review Committee recommendation. |
cspec
|
| BP7 | N/A | Not applicable: the variant is missense and exonic, whereas PTEN BP7 covers only synonymous or intronic variants at or beyond +7/-21. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.